Switch theme
Sign up to access all valuation multiples
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
2020
335
LTM Revenue $288M
LTM EBITDA $43.0M
$496M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Waldencast has a last 12-month revenue (LTM) of $288M and a last 12-month EBITDA of $43.0M.
In the most recent fiscal year, Waldencast achieved revenue of $274M and an EBITDA of $28.6M.
Waldencast expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Waldencast valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $288M | XXX | $274M | XXX | XXX | XXX |
| Gross Profit | $210M | XXX | $192M | XXX | XXX | XXX |
| Gross Margin | 73% | XXX | 70% | XXX | XXX | XXX |
| EBITDA | $43.0M | XXX | $28.6M | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 10% | XXX | XXX | XXX |
| EBIT | -$38.0M | XXX | -$53.6M | XXX | XXX | XXX |
| EBIT Margin | -13% | XXX | -20% | XXX | XXX | XXX |
| Net Profit | -$36.9M | XXX | -$42.4M | XXX | XXX | XXX |
| Net Margin | -13% | XXX | -15% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $152M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Waldencast's stock price is $3.
Waldencast has current market cap of $328M, and EV of $496M.
See Waldencast trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $496M | $328M | XXX | XXX | XXX | XXX | $-0.30 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Waldencast has market cap of $328M and EV of $496M.
Waldencast's trades at 1.8x EV/Revenue multiple, and 17.3x EV/EBITDA.
Equity research analysts estimate Waldencast's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Waldencast has a P/E ratio of -8.9x.
See valuation multiples for Waldencast and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $328M | XXX | $328M | XXX | XXX | XXX |
| EV (current) | $496M | XXX | $496M | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | 11.5x | XXX | 17.3x | XXX | XXX | XXX |
| EV/EBIT | -13.1x | XXX | -9.3x | XXX | XXX | XXX |
| EV/Gross Profit | 2.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | -8.9x | XXX | -7.7x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -41.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialWaldencast's last 12 month revenue growth is 14%
Waldencast's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.7M for the same period.
Waldencast's rule of 40 is -1% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Waldencast's rule of X is 50% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Waldencast and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | 19% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -1% | XXX | 24% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 50% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.8M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.7M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 90% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Waldencast acquired XXX companies to date.
Last acquisition by Waldencast was XXXXXXXX, XXXXX XXXXX XXXXXX . Waldencast acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Waldencast founded? | Waldencast was founded in 2020. |
| Where is Waldencast headquartered? | Waldencast is headquartered in United States of America. |
| How many employees does Waldencast have? | As of today, Waldencast has 335 employees. |
| Who is the CEO of Waldencast? | Waldencast's CEO is Mr. Michel Brousset. |
| Is Waldencast publicy listed? | Yes, Waldencast is a public company listed on NAS. |
| What is the stock symbol of Waldencast? | Waldencast trades under WALD ticker. |
| When did Waldencast go public? | Waldencast went public in 2021. |
| Who are competitors of Waldencast? | Similar companies to Waldencast include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Waldencast? | Waldencast's current market cap is $328M |
| What is the current revenue of Waldencast? | Waldencast's last 12 months revenue is $288M. |
| What is the current revenue growth of Waldencast? | Waldencast revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Waldencast? | Current revenue multiple of Waldencast is 1.7x. |
| Is Waldencast profitable? | Yes, Waldencast is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Waldencast? | Waldencast's last 12 months EBITDA is $43.0M. |
| What is Waldencast's EBITDA margin? | Waldencast's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Waldencast? | Current EBITDA multiple of Waldencast is 11.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
